The Mouse MPO ELISA Kit is to be used for the quantitative determination of mouse MPO in plasma, tissue homogenate, BALF and cell culture supernatant samples. The Eagle Biosciences Mouse MPO ELISA Kit is for research use only and not for diagnostic or therapeutic procedures.


The Mouse MPO ELISA Kit is For Research Use Only

Sizes: 1×96 wells and 2×96 wells
Sensitivity: 1.6 ng/ml
Standard Range: 1.6-100 ng/ml
Incubation Time: 3.5 hours
Sample Type: Plasma, tissue homogenate and cell culture supernatants.
Sample Size: 100 µl
Alternative Names:Myeloperoxidase

Assay Principle

The mouse MPO ELISA is a ready-to-use solid-phase enzyme-linked immunosorbent assay based on the sandwich principle with a working time of 3½ hours. The efficient format of a plate with twelve disposable 8-well strips allows free choice of batch size for the assay. Samples and standards are incubated in microtiter wells coated with antibodies recognizing mouse MPO. Biotinylated tracer antibody will bind to captured mouse MPO. Streptavidin-peroxidase conjugate will bind to the biotinylated tracer antibody. Streptavidin-peroxidase conjugate will react with the substrate, tetramethylbenzidine (TMB). The enzyme reaction is stopped by the addition of oxalic acid. The absorbance at 450 nm is measured with a spectrophotometer. A standard curve is obtained by plotting the absorbance (linear) versus the corresponding concentrations of the mouse MPO standards (log). The mouse MPO concentration of samples, which are run concurrently with the standards, can be determined from the standard curve.

Related Products

MPO Serum Plasma ELISA

Additional Information

Assay Background

Myeloperoxidase (MPO) is a glycoprotein with a alpha2beta2 heteromultimer expressed in all cells of the myeloid linage. MPO is abundantly present in azurophilic granules of polymorphonuclear neutrophils. It is an important enzyme used during phagocytic lysis of engulfed foreign particles which takes part in the defense of the organism through production of hypochlorous acid (HOCl), a potent oxidant. MPO is rapidly released by activated polymorphonuclear neutrophils. Involvement of MPO has been described in numerous diseases such as atherosclerosis, lung cancer, Alzheimer’s disease and multiple sclerosis. Autoimmune antibodies to MPO are involved in Wegeners disease. Since the discovery of MPO deficiency, initially regarded as rare and restricted to patients suffering from severe infections, MPO has attracted more clinical attention.


Product Documents


Please note: All documents above are for reference use only and should not be used in place of the documents included with this physical product. If digital copies are needed, please contact us.

Product Citations